Houston, Texas
Cancer surgery and procedure trials in Houston, TX
79 cancer surgery and procedure studies are recruiting participants at sites in Houston as of November 18, 2026, according to ClinicalTrials.gov. Cancer Surgery Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Houston at a glance
- 79 studies are recruiting at a site in Houston.
- By phase: Phase 1 (8), Phase 1/2 (3), Phase 2 (21), Phase 3 (20), No phase (14), Observational (13). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (58), government (17), industry (4).
- By research area: Breast Cancer (22), Lymphoma (20), Lung Cancer (15), Melanoma (8), Prostate Cancer (8), Pancreatic Cancer (6).
- Most recent update to one of these records: November 18, 2026.
Breast cancer studies recruiting in Houston
Basic details from each study's public record (the 30 most recently updated of 79). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UT MD Anderson Cancer Center
- Registry record
- NCT05111561 · updated
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
- Phase 1
- Ages 12 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UT MD Anderson Cancer Center
- Registry record
- NCT05372640 · updated
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Phase 2
- All ages
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Lyndon Baines Johnson General Hospital · UT MD Anderson Cancer Center
- Registry record
- NCT05564377 · updated
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Houston Methodist Hospital · Houston Methodist West Hospital · Methodist Willowbrook Hospital
- Registry record
- NCT07391774 · updated
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center · Ben Taub General Hospital · UT MD Anderson - West Houston
- Registry record
- NCT06058377 · updated
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT03941756 · updated
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- University of California, San Francisco
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT05964504 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- UT MD Anderson Cancer Center
- Registry record
- NCT05334069 · updated
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT07407920 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Houston, TX on ClinicalTrials.gov.
Lung cancer studies recruiting in Houston
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Houston Methodist Hospital · Houston Methodist West Hospital
- Registry record
- NCT04267848 · updated
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Houston Methodist Hospital · Houston Methodist West Hospital · Methodist Willowbrook Hospital
- Registry record
- NCT04181060 · updated
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- The University of Texas MD Anderson Cancer Center ( Site 0009)
- Registry record
- NCT04165798 · updated
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- VA Office of Research and Development
- Study site
- Michael E. DeBakey VA Medical Center, Houston, TX
- Registry record
- NCT02984761 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Houston, TX on ClinicalTrials.gov.
Prostate cancer studies recruiting in Houston
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
- Phase 2
- Ages 18 and older
- Male participants
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UT MD Anderson Cancer Center
- Registry record
- NCT05691465 · updated
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- NRG Oncology
- Study sites
- UT MD Anderson - West Houston · UT MD Anderson Cancer Center
- Registry record
- NCT05946213 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Houston, TX on ClinicalTrials.gov.
Lymphoma studies recruiting in Houston
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Phase 2
- Up to 365 days
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
- Registry record
- NCT06317662 · updated
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UT MD Anderson Cancer Center
- Registry record
- NCT06337318 · updated
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study sites
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center · UT MD Anderson Cancer Center
- Registry record
- NCT04726241 · updated
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT05011045 · updated
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Phase 2
- Ages 1 to 30
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center · UT MD Anderson Cancer Center
- Registry record
- NCT04546399 · updated
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- Phase 3
- Ages 5 to 60
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center · UT MD Anderson Cancer Center
- Registry record
- NCT05675410 · updated
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- The University of Texas M D Anderson Cancer Center
- Registry record
- NCT05773040 · updated
Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT06218602 · updated
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
- Phase 3
- Ages 18 to 39
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Houston Methodist Hospital
- Registry record
- NCT03150693 · updated
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center · Ben Taub General Hospital
- Registry record
- NCT07215910 · updated
Personalized NK Cell Therapy in CBT
- Phase 2
- Ages 15 to 80
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT02727803 · updated
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study sites
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center · Ben Taub General Hospital
- Registry record
- NCT05890352 · updated
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Phase 2
- From 366 days, up to 46 years
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
- Registry record
- NCT06124157 · updated
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study site
- UT MD Anderson Cancer Center
- Registry record
- NCT07356245 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Houston, TX on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Houston
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UT MD Anderson Cancer Center
- Registry record
- NCT05372614 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Houston, TX on ClinicalTrials.gov.
Ask about studies near Houston
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.
Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections